
DERM
USDJourney Medical Corporation Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$8.410
고가
$9.010
저가
$8.260
거래량
0.22M
기업 기본 정보
시가총액
236.8M
산업
Drug Manufacturers - Specialty & Generic
국가
United States
거래 통계
평균 거래량
0.16M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea
Journey Medical Corporation to Participate in October 2025 Investor Conferences
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing
관련 주식
SAH
Sonic Automotive Inc.
CSLRW
Complete Solaria Inc. Warrants
BHFAM
Brighthouse Financial Inc. Depositary shares each representing a 1/1000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock Series D
ARWR
Arrowhead Pharmaceuticals Inc.
JBI
Janus International Group Inc.
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기